SELFEMRA Trademark

Trademark Overview

On Wednesday, July 14, 2004, a trademark application was filed for SELFEMRA with the United States Patent and Trademark Office. The USPTO has given the SELFEMRA trademark a serial number of 78450625. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, March 20, 2015. This trademark is owned by TEVA Pharmaceuticals USA Inc.. The SELFEMRA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparation indicated for the treatment of premenstrual dysphoric disorder
selfemra

General Information

Serial Number78450625
Word MarkSELFEMRA
Filing DateWednesday, July 14, 2004
Status710 - CANCELLED - SECTION 8
Status DateFriday, March 20, 2015
Registration Number3490147
Registration DateTuesday, August 19, 2008
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 30, 2005

Trademark Statements

Goods and ServicesPharmaceutical preparation indicated for the treatment of premenstrual dysphoric disorder

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, March 20, 2015
Primary Code005
First Use Anywhere DateTuesday, May 20, 2008
First Use In Commerce DateTuesday, May 20, 2008

Trademark Owner History

Party NameTEVA Pharmaceuticals USA Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressHorsham, PA 190448055
Party NameTEVA Pharmaceuticals USA Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHorsham, PA 190448055
Party NameTEVA Pharmaceuticals USA Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNorth Wales, PA 194541090

Trademark Events

Event DateEvent Description
Friday, March 20, 2015CANCELLED SEC. 8 (6-YR)
Tuesday, August 19, 2008REGISTERED-PRINCIPAL REGISTER
Tuesday, July 15, 2008LAW OFFICE REGISTRATION REVIEW COMPLETED
Tuesday, July 15, 2008ASSIGNED TO LIE
Monday, July 14, 2008ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, June 6, 2008STATEMENT OF USE PROCESSING COMPLETE
Monday, June 2, 2008USE AMENDMENT FILED
Monday, June 2, 2008TEAS STATEMENT OF USE RECEIVED
Thursday, April 10, 2008EXTENSION 5 GRANTED
Friday, March 21, 2008EXTENSION 5 FILED
Friday, March 21, 2008TEAS EXTENSION RECEIVED
Friday, October 5, 2007EXTENSION 4 GRANTED
Wednesday, September 26, 2007EXTENSION 4 FILED
Wednesday, September 26, 2007TEAS EXTENSION RECEIVED
Thursday, July 19, 2007EXTENSION 3 GRANTED
Thursday, April 5, 2007EXTENSION 3 FILED
Thursday, April 5, 2007TEAS EXTENSION RECEIVED
Tuesday, December 5, 2006EXTENSION 2 GRANTED
Wednesday, October 18, 2006EXTENSION 2 FILED
Wednesday, October 18, 2006TEAS EXTENSION RECEIVED
Monday, April 3, 2006EXTENSION 1 GRANTED
Thursday, March 16, 2006EXTENSION 1 FILED
Thursday, March 16, 2006TEAS EXTENSION RECEIVED
Tuesday, November 22, 2005NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 30, 2005PUBLISHED FOR OPPOSITION
Wednesday, August 10, 2005NOTICE OF PUBLICATION
Monday, April 25, 2005LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, April 25, 2005ASSIGNED TO LIE
Friday, April 1, 2005ASSIGNED TO LIE
Monday, March 28, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 28, 2005TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 22, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 25, 2005TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 22, 2005TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 25, 2005NON-FINAL ACTION E-MAILED
Friday, February 25, 2005NON-FINAL ACTION WRITTEN
Thursday, February 17, 2005ASSIGNED TO EXAMINER
Thursday, July 22, 2004NEW APPLICATION ENTERED IN TRAM

Related Keywords

selfemra dysphoric disorder premenstrual treatment preparation indicated pharmaceutical